Dechra Pharmaceuticals Share Price (DPH)

0.00 0.00 (0.00%) delayed: 5:49AM BST
Bid price 1,848.00 Open price 0.00
Ask price 1,850.00 Prev close 1,850.00
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 43.69
Market Capitalisation (£m) 1,709.39 Gross Gearing (%) 50.67
Shares in issue (m) 93.10 Debt Ratio 44.06
P/E Ratio 131.14 Debt-to-Equity Ratio 0.77
Total dividends per share (p) 18.46 Assets / Equity Ratio 2.03
Dividend Yield (%) 1.04 Price to book value 6.18
Dividend cover (x) 0.74 ROCE (%) 2.94
Earning per share (p) 14.00 EPS Growth (%) -36.77
52 week high / low 1,851.00 / 811.00 DPS Growth (%) 8.97

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
24/04/2017 TOUT Ian Page CEO 6,600
21/03/2017 SELL Tony Griffin ED 3,500
05/12/2016 BUY Tony Rice NED 120,000
30/11/2016 SELL Ian Page CEO 58,633
30/11/2016 SELL Tony Griffin ED 17,133

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

11:42 18/05/2017

Holding(s) in Company

RNS Number : 5577F Dechra Pharmaceuticals PLC 18 May 2017     TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii...

16:42 03/05/2017

Director/PDMR Shareholding

RNS Number : 1053E Dechra Pharmaceuticals PLC 03 May 2017         3 May 2017   Dechra® Pharmaceuticals PLC (Dechra or the Company)      In accordance with article 19(1) of the Market Abuse Regulations, the Company announces that on 2 May...

14:27 28/04/2017

Total Voting Rights

RNS Number : 7342D Dechra Pharmaceuticals PLC 28 April 2017           28 April 2017   Dechra® Pharmaceuticals PLC (Dechra or the Company)      Total Voting Rights     In conformity with DTR 5.6.1R, the Company notifies the market...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p and...

Register now for FREE Dechra Pharmaceuticals share price discussions